| GRSRX | IRGIX | GRSRX / IRGIX | |
| Total Expense Ratio | 1.34 | 0.90 | 149% |
| Annual Report Gross Expense Ratio | 1.34 | 1.06 | 126% |
| Fund Existence | 11 years | 20 years | - |
| Gain YTD | 8.633 | 7.189 | 120% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.12B | 133M | 1,591% |
| Annual Yield % from dividends | 2.20 | 2.95 | 75% |
| Returns for 1 year | 8.06 | 6.55 | 123% |
| Returns for 3 years | 20.60 | 20.31 | 101% |
| Returns for 5 years | 14.93 | 15.82 | 94% |
| Returns for 10 years | 38.97 | 23.33 | 167% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BRWSX | 27.58 | 0.02 | +0.07% |
| MFS Blended Research Growth Eq R2 | |||
| SCPIX | 54.76 | -0.02 | -0.04% |
| DWS S&P 500 Index S | |||
| SGPSX | 85.75 | -0.13 | -0.15% |
| ProFunds Small Cap Growth Svc | |||
| JFNIX | 81.75 | -0.19 | -0.23% |
| Janus Henderson Global Life Sciences I | |||
| VSFAX | 25.44 | -0.07 | -0.27% |
| Federated Hermes MDT Small Cap Value A | |||